PERSISTENT MULLERIAN DUCT SYNDROME
Abstract
Persistent Mullerian Duct Syndrome is extremely rare. Our patient, a 32 years old male, with history of orchidectomy presented with mass abdomen. He was initially diagnosed with seminoma and subsequently treated with chemotherapy. Biopsy of the mass showed germ cell tumour and MRI abdomen revealed female rudimentary organs confirmed on per operative and later on histopathology. Karyotype was 46 XY.References
Patil V, Muktinaini S, Patil R, Verma A. Persistent müllerian duct syndrome: a case report. Indian J Surg 2013;75(1):460–2.
Ren X, Wu D, Gong C. Persistent Müllerian duct syndrome: A case report and review. Exp Ther Med 2017;14(6):5779–84.
Bhatti AB, Ahmed I, Ghauri RK, Saeed Q, Mir K. Clinical profile, treatment and survival outcome of testicular tumors: a Pakistani perspective. Asian Pac J Cancer Prev 2014;15(1):277–80.
Schaffar R, Pant S, Bouchardy C, Schubert H, Rapiti E. Testicular cancer in Geneva, Switzerland, 1970–2012: incidence trends, survival and risk of second cancer. BMC Urol 2019;19(1):64.
Chia VM, Quraishi SM, Devesa SS, Purdue MP, Cook MB, McGlynn KA. International trends in the incidence of testicular cancer, 1973-2002. Cancer Epidemiol Biomarkers Prev 2010;19(5):1151–9.
Gill MS, Shah SH, Soomro IN, Kayani N, Hasan SH. Morphological pattern of testicular tumors. J Pak Med Assoc 2000;50(4):110–2.
Filler RM, Hardy BE. Testicular tumors in children. World J Surg 1980;4(1):63–7.
Mushtaq S, Jamal S, Mamoon N, Akbar N, Khadim T. The pathological spectrum of malignant testicular tumours in northern Pakistan. J Pak Med Assoc 2007;57(10):499–501.
Wanderås EH, Tretli S, Fossra SD. Trends in incidence of testicular cancer in Norway 1955–1992. Eur J Cancer 1995;31(12):2044–8.
Einhorn LH, Williams SD, Loehrer PJ, Birch R, Drasga R, Omura G, et al. Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol. J Clin Oncol 1989;7(3):387–91
Nigam M, Aschebrook-Kilfoy B, Shikanov S, Eggener S. Increasing incidence of testicular cancer in the United States and Europe between 1992 and 2009. World J Urol 2015;33(5):623–31.
Published
Issue
Section
License
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
